Oct. 24 at 1:24 PM
$ADHC @ADHCMANAGEMENT - American Diversified Holdings Corp. Coverage Initiation Report Harbinger Research initiates coverage on GlucoGuard with in-depth report—spotlighting AI-driven growth, valuation model, & multi-year upside in digital health.
To access the research report, please visit the Harbinger Research website at:
https://api.newsfilecorp.com/redirect/V7NMQIeJqQ
"Management views the
$43 M enterprise value to be conservative due to ability of the GlucoGuard technology to meet the unmet need of hypoglycemia and the severe problems of "Death in Bed"," commented ADHC. "Additionally, this report does not incorporate GlucoGuards' AI and Predictive learning software components and related IP due to its developing nature," concluded ADHC.
Key Aspects of the Report:
✅537mm Diabetic Patients Worldwide.
✅37 mm Diabetic Patients In the US.
✅3.7 Type 1 Diabetics in the US.
✅190k to 380K Potential Patients in the US.
✅A potential market of
$360 MM to
$720MM in revenues.
